Moderna Inc. (NASDAQ:MRNA) investors spent months treating the company’s cancer vaccine as a potential cure. Last week, leaked trial data delivered a reality check. The stock plunged roughly 26% intra[...]
Read moreArticles written by Erica Kollmann
QUICK SPARK: S&P 500 Bull Market Turns 4, More Than Doubling From Its 2022 Low
The current S&P 500 bull market is marking its fourth anniversary on Monday, Oct. 12, 2026 — a run that began with the index’s bear-market closing low of 3,577.03 on Oct. 12, 2022. S&P 500 Rea[...]
Read moreSpaceX Options Frenzy Sparks Talk of Gamma Squeeze To $400
Space Exploration Technologies Corp. (NASDAQ:SPCX) options began trading Tuesday on Cboe Global Markets Inc. (CBOE:CBOE) and Nasdaq Inc. (NASDAQ:NDAQ), marking one of the most closely watched options[...]
Read moreWill Quantinuum Lift Other Quantum Stocks — Or Eat Their Lunch?
Wall Street has a quantum computing problem, and it’s not about qubits. It’s about how the market prices the entire sector as a single trade. When the Trump administration announced $2 billion in fede[...]
Read moreWebull Sheds Light on Overnight Trading with Unified Data Feed
Webull Corp. (NASDAQ:BULL) announced on Wednesday the global launch of a first-of-its-kind consolidated market data feed for overnight trading in U.S. stocks. The new tool is designed to provide inv[...]
Read more